EDAP
- EDAP TMS S.A.
()
Overview
Company Summary
EDAP TMS S.A. (EDAP) is a global leader in the development, manufacturing, and marketing of minimally invasive medical devices for the treatment of urological conditions. The company focuses mainly on innovative technologies targeting diseases of the prostate gland.
EDAP offers a range of advanced medical devices, including the flagship product called Ablatherm-HIFU (High-Intensity Focused Ultrasound). This innovative device utilizes high-frequency ultrasound waves to precisely destroy cancerous tissue in the prostate without damaging surrounding healthy tissue. Ablatherm-HIFU is recognized as a non-invasive alternative to traditional surgical treatments for localized prostate cancer.
In addition to Ablatherm-HIFU, EDAP provides a range of complementary products and services. These include lithotripsy devices for non-invasive treatment of urinary tract stones, such as the Sonolith i-move, which utilizes shock waves to break down kidney or ureter stones. The company also offers consumables, accessories, and maintenance services to support its devices.
EDAP operates globally, serving healthcare professionals, hospitals, and clinics in more than 60 countries. The company has established a strong presence in the European, Asian, and North American markets. EDAP collaborates with leading urologists and medical institutions to enhance patient outcomes and expand the use of its innovative technologies.
Overall, EDAP TMS S.A. is dedicated to improving the quality of life for patients suffering from urological conditions through the development and commercialization of minimally invasive medical devices.